Bayer AG (XSWX:BAYN) Ending Cash Position: CHF5,213 Mil (As of Mar. 2026)


XSWX:BAYN Bayer AG XSWX:BAYN
35 GF Score
Price CHF48.69
GF Value CHF24.98
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Bayer AG Ending Cash Position?

Bayer AG XSWX:BAYN +2.01% 35 Ending Cash Position is CHF5,213 Mil as of Mar. 2026. GuruFocus rates XSWX:BAYN with a GF Score™ of 35/100 and a GF Value™ of CHF24.98 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Bayer AG's Ending Cash Position for the quarter that ended in Mar. 2026 was CHF5,213 Mil.

Bayer AG's quarterly Ending Cash Position increased from Sep. 2025 (CHF5,510 Mil) to Dec. 2025 (CHF6,225 Mil) but then declined from Dec. 2025 (CHF6,225 Mil) to Mar. 2026 (CHF5,213 Mil).

Bayer AG's annual Ending Cash Position increased from Dec. 2023 (CHF5,571 Mil) to Dec. 2024 (CHF5,780 Mil) and increased from Dec. 2024 (CHF5,780 Mil) to Dec. 2025 (CHF6,225 Mil).

Bayer AG Ending Cash Position Related Terms

Bayer AG Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Bayer AG's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bayer AG Ending Cash Position Chart

Bayer AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,749.65 5,103.08 5,570.75 5,780.00 6,224.97

Bayer AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,835.30 4,274.22 5,510.10 6,224.97 5,213.47
XSWX:BAYN
35GF Score
Bayer AG XSWX:BAYN
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bayer AG Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Bayer AG's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=5777.059+447.906
=6,225

Bayer AG's Ending Cash Position for the quarter that ended in Mar. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=6059.933+-846.46
=5,213

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of CHF5,213 Mil mean?
Bayer AG (XSWX:BAYN) has a Ending Cash Position of CHF5,213 Mil as of Mar. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Bayer AG and its competitors.
Is Bayer AG's Ending Cash Position too high?
Bayer AG's current Ending Cash Position is CHF5,213 Mil. Overall, Bayer AG has a GF Score™ of 35/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bayer AG's Ending Cash Position compare to LLY and JNJ?
Bayer AG's Ending Cash Position of CHF5,213 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Drug Manufacturers company?
A good Ending Cash Position depends on the Drug Manufacturers industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Bayer AG and its competitors. Bayer AG's current Ending Cash Position is CHF5,213 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bayer AG stock overvalued right now?
Based on GuruFocus' analysis, Bayer AG (XSWX:BAYN) is currently considered Significantly Overvalued. The stock's GF Value™ is CHF24.98, compared to a current price of CHF48.69 — trading 94.9% above its estimated fair value. The current Ending Cash Position is CHF5,213 Mil. Bayer AG's overall GF Score™ is 35/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Bayer AG (XSWX:BAYN), the current Ending Cash Position is CHF5,213 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bayer AG (XSWX:BAYN) Overvalued in 2026?

Based on GuruFocus' analysis, Bayer AG stock appears to be overvalued. The current stock price of CHF48.69 is trading 94.9% above its estimated GF Value™ of CHF24.98. GuruFocus considers Bayer AG to be Significantly Overvalued.

Key valuation signals for XSWX:BAYN:

  • Ending Cash Position: CHF5,213 Mil
  • GF Value™: CHF24.98 vs. price of CHF48.69 (94.9% above fair value)
  • GF Score™: 35/100 with 7 warning signs

No single metric tells the full story. See the XSWX:BAYN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bayer AG Business Description

Address Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs (about 38% of total sales in 2025) as well as vitamins and other consumer healthcare products (13% of total). The firm's crop science business (47% of total) sells seeds, pesticides, herbicides, and fungicides, which was expanded through its 2018 acquisition of Monsanto.
35GF Score

Get the complete analysis for XSWX:BAYN

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF48.69
Price
CHF24.98
GF Value